SEC Form 4 · accession 0001209191-16-127485
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Heath Lukatch
Director
Period of report
Jun 10, 2016
Accepted (ET)
Jun 13, 2016 · 8:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.83 | Jun 10, 2016 | A | 12,500 | A | — | Jun 9, 2026 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant.